$ News

Why Xinyuan Real Estate Co., Ltd. (XIN) Soared on Monday

Creditors file petition for Chinese developer Xinyuan Real Estate’s bankruptcy

Xinyuan Real Estate Alters Terms on 2027 Senior Notes

Shandong Xinhua Pharmaceutical Switches Hong Kong Share Registrar

Shandong Xinhua’s Mixed Financial Performance in 2024

Shandong Xinhua Pharmaceutical Announces Subsidiary Merger

Shandong Xinhua Renews Key Transaction Agreements

Shandong Xinhua Receives Key Drug Approval

Shandong Xinhua Pharma Secures FDA Approval for New Drug

Xinyuan Real Estate Faces Revenue and Profit Challenges

Shandong Xinhua Pharmaceutical Passes Key Resolutions

Xinyuan Real Estate (XIN) Stock Drops Amid Market Volatility

Shandong Xinhua Pharma Announces Board Meeting

XIN Stock Surges Over 6% Amid Real Estate Sector Gains

Shandong Xinhua Pharma’s Upcoming EGM

Shandong Xinhua Proposes Governance Amendments

BitFuFu Announces Changes in Board of Directors

Shandong Xinhua Declares Year-End Dividend

Shandong Xinhua Pharma Announces AGM Results and Dividend

Xinhua Pharma Secures Drug Registration Certificate